The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term growth of capital.
The fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in common stocks or securities convertible into common stocks of foreign companies and depositary receipts evidencing ownership in such securities. At least 75% of its net assets will be invested in countries represented in the Morgan Stanley Capital International Europe, Australasia and Far East (MSCI EAFE®) Index. The fund may invest up to 25% of its net assets in stocks of companies located in countries (other than the United States) not represented in the MSCI EAFE Index.
The average market capitalization across the BNY Mellon International Equity C MF is 142.48B. The market cap for tickers in the group ranges from 95.23M to 327.81B. NSRGF holds the highest valuation in this group at 327.81B. The lowest valued company is SUP at 95.23M.
The average weekly volume growth across all stocks in the BNY Mellon International Equity C MF was -58%. For the same stocks of the MF, the average monthly volume growth was -66% and the average quarterly volume growth was -38%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 54
P/E Growth Rating: 59
Price Growth Rating: 47
SMR Rating: 59
Profit Risk Rating: 53
Seasonality Score: -43 (-100 ... +100)